A Personalised Neo-antigen Viro-Immunotherapy Platform for Human Solid Tumours
Time: 11:00 am
day: Day Two
Details:
- How to identify immunogenic neoantigen epitopes? Is computational prediction sufficient?
- How to optimise tumour-targeted replicating oncolytic virus to unlock the power of virotherapy for cancer treatment?
- How to combine oncolytic viruses and neoantigens as a synergistic frontier for cancer treatment?
